These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 3881591)

  • 1. Uropathogenic properties of Proteus mirabilis and Proteus vulgaris.
    Peerbooms PG; Verweij AM; MacLaren DM
    J Med Microbiol; 1985 Feb; 19(1):55-60. PubMed ID: 3881591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine.
    Peerbooms PG; Verweij AM; Oe PL; MacLaren DM
    Antonie Van Leeuwenhoek; 1986; 52(1):53-62. PubMed ID: 3524444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
    Kotelko K; Kaca W; Rózalski A; Deka M
    Acta Microbiol Pol; 1983; 32(4):345-51. PubMed ID: 6202102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell invasiveness of Proteus mirabilis and Proteus vulgaris strains.
    Rózalski A; Długońska H; Kotełko K
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):505-12. PubMed ID: 3296994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and properties of haemolysins from clinical isolates of the Proteeae.
    Senior BW; Hughes C
    J Med Microbiol; 1988 Jan; 25(1):17-25. PubMed ID: 3275780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some biological features of proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains.
    Rózalski A; Wykrota M
    Acta Microbiol Pol; 1986; 35(1-2):57-9. PubMed ID: 2426926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth, cellular differentiation and virulence factor expression by Proteus mirabilis in vitro and in vivo.
    Zunino P; Piccini C; Legnani-Fajardo C
    J Med Microbiol; 1999 Jun; 48(6):527-534. PubMed ID: 10359301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare occurrence of Proteus vulgaris in faeces: a reason for its rare association with urinary tract infections.
    Senior BW; Leslie DL
    J Med Microbiol; 1986 Mar; 21(2):139-44. PubMed ID: 3512839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of correlative relations between virulence and other biological properties of Proteus].
    Vitvits'kii VM; Dikii BM
    Mikrobiol Zh; 1975; 37(6):748-51. PubMed ID: 1107766
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
    Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
    Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ureases of Proteus strains in relation to virulence for the urinary tract.
    Senior BW; Bradford NC; Simpson DS
    J Med Microbiol; 1980 Nov; 13(4):507-12. PubMed ID: 7001026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteus mirabilis isolates of different origins do not show correlation with virulence attributes and can colonize the urinary tract of mice.
    Sosa V; Schlapp G; Zunino P
    Microbiology (Reading); 2006 Jul; 152(Pt 7):2149-2157. PubMed ID: 16804188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of RpoE in uropathogenic Proteus mirabilis.
    Liu MC; Kuo KT; Chien HF; Tsai YL; Liaw SJ
    Infect Immun; 2015 Mar; 83(3):966-77. PubMed ID: 25547796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
    Fraga M; Scavone P; Zunino P
    Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection.
    Jacobsen SM; Lane MC; Harro JM; Shirtliff ME; Mobley HL
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):180-93. PubMed ID: 18194341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fimbriae of uropathogenic Proteus mirabilis.
    Rocha SP; Pelayo JS; Elias WP
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swarming growth and resistance of Proteus penneri and Proteus vulgaris strains to normal human serum.
    Kwil I; Kaźmierczak D; Różalski A
    Adv Clin Exp Med; 2013; 22(2):165-75. PubMed ID: 23709372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
    Sekaninová G; Kolárová M
    Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterisation of dog uropathogenic Proteus mirabilis strains.
    Gaastra W; van Oosterom RA; Pieters EW; Bergmans HE; van Dijk L; Agnes A; ter Huurne HM
    Vet Microbiol; 1996 Jan; 48(1-2):57-71. PubMed ID: 8701578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides.
    Torzewska A; Stączek P; Róźalski A
    J Med Microbiol; 2003 Jun; 52(Pt 6):471-477. PubMed ID: 12748265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.